Akeso (FRA:4RY) Beginning Cash Position: €173.5 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:4RY Akeso Inc FRA:4RY
51 GF Score
Price €11.27
GF Value €18.83
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Akeso Beginning Cash Position?

Akeso FRA:4RY 51 Beginning Cash Position is €173.5 Mil as of Dec. 2025. GuruFocus rates FRA:4RY with a GF Score™ of 51/100 and a GF Value™ of €18.83 (Possible Value Trap). The stock has 5 warning signs investors should review.

Akeso's Beginning Cash Position for the quarter that ended in Dec. 2025 was €173.5 Mil.

Akeso's quarterly Beginning Cash Position increased from Dec. 2024 (€326.3 Mil) to Jun. 2025 (€352.1 Mil) but then declined from Jun. 2025 (€352.1 Mil) to Dec. 2025 (€173.5 Mil).

Akeso's annual Beginning Cash Position declined from Dec. 2023 (€268.7 Mil) to Dec. 2024 (€202.3 Mil) but then increased from Dec. 2024 (€202.3 Mil) to Dec. 2025 (€353.5 Mil).

Akeso Beginning Cash Position Related Terms

Akeso Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Akeso's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Akeso Beginning Cash Position Chart

Akeso Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beginning Cash Position
Get a 7-Day Free Trial 373.01 357.69 268.72 202.30 353.54

Akeso Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 550.33 197.50 326.26 352.06 173.52
FRA:4RY
51GF Score
Akeso Inc FRA:4RY
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Akeso Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of €173.5 Mil mean?
Akeso (FRA:4RY) has a Beginning Cash Position of €173.5 Mil as of Dec. 2025. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Akeso and its competitors.
Is Akeso's Beginning Cash Position too high?
Akeso's current Beginning Cash Position is €173.5 Mil. Overall, Akeso has a GF Score™ of 51/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Akeso's Beginning Cash Position compare to VRTX and REGN?
Akeso's Beginning Cash Position of €173.5 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Biotechnology company?
A good Beginning Cash Position depends on the Biotechnology industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Akeso and its competitors. Akeso's current Beginning Cash Position is €173.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Akeso stock overvalued right now?
Based on GuruFocus' analysis, Akeso (FRA:4RY) is currently considered Possible Value Trap. The stock's GF Value™ is €18.83, compared to a current price of €11.27 — trading 40.1% below its estimated fair value. The current Beginning Cash Position is €173.5 Mil. Akeso's overall GF Score™ is 51/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Akeso (FRA:4RY), the current Beginning Cash Position is €173.5 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Akeso (FRA:4RY) Overvalued in 2026?

Based on GuruFocus' analysis, Akeso stock appears to be undervalued. The current stock price of €11.27 is trading 40.1% below its estimated GF Value™ of €18.83. GuruFocus considers Akeso to be Possible Value Trap.

Key valuation signals for FRA:4RY:

  • Beginning Cash Position: €173.5 Mil
  • GF Value™: €18.83 vs. price of €11.27 (40.1% below fair value)
  • GF Score™: 51/100 with 5 warning signs

No single metric tells the full story. See the FRA:4RY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Akeso Business Description

Address No. 6, Shennong Road, Torch Development Zone, Guangdong Province, Zhongshan, CHN, 528437
Akeso Inc is an investment holding company. The Company's subsidiaries were involved in research and development, production, and commercialization of biopharmaceutical products. The company has developed more than 50 drug candidates, including 15 bispecific antibody/multispecific antibody/bispecific antibody ADC/ADC/TCE drugs, with 27 drugs in clinical development. The majority of the company's revenue is derived from Mainland China, and it also has its presence in the USA and Other regions.
51GF Score

Get the complete analysis for FRA:4RY

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€11.27
Price
€18.83
GF Value